Sanno N, Teramoto A, Matsuno A, Takekoshi S, Osamura R Y
Department of Pathology, Tokai University School of Medicine, Kanagawa, Japan.
J Clin Endocrinol Metab. 1995 Aug;80(8):2518-22. doi: 10.1210/jcem.80.8.7543115.
TSH-secreting pituitary adenomas are rare. The transcriptional expression (messenger ribonucleic acids: mRNAs) of TSH beta, GH, and PRL in five patients with TSH-secreting pituitary adenoma was studied by the in situ hybridization (ISH) method in order to elucidate their multiple hormone production. These patients showed inappropriately elevated serum TSH and alpha-subunit levels as well as pituitary mass lesions. The tissues from pituitary adenomas were obtained at the time of transsphenoidal surgery and revealed immunohistochemically the expression of alpha-subunit and TSH beta in all patients. Four adenomas were immunohistochemically associated with GH or PRL localization. The presence of pituitary-specific transcriptional factor Pit-1 was demonstrated in all adenomas in the nuclei of many cells. By ISH, signals for TSH beta mRNA were present in all five cases in many adenoma cells. Expression of GH mRNA and PRL mRNA were detected not only in four adenomas in which both hormonal products were immunolocalized but also in one adenoma that was immunohistochemically negative for GH and PRL. Combined staining by ISH and immunohistochemistry revealed the expression of GH mRNA and PRL mRNA in TSH beta-immunoreactive cells. Our findings indicate that TSH-secreting adenomas are multihormone-producing and could arise from precursor or stem cells rather than from differentiated TSH-secreting cells. It is suggested that ISH combined with immunohistochemistry may provide additional detailed information concerning the multidirectional histogenesis of this rare type of adenoma.
促甲状腺激素分泌型垂体腺瘤较为罕见。为了阐明五例促甲状腺激素分泌型垂体腺瘤患者多种激素的产生情况,采用原位杂交(ISH)方法研究了促甲状腺激素β(TSHβ)、生长激素(GH)和催乳素(PRL)的转录表达(信使核糖核酸:mRNA)。这些患者血清促甲状腺激素和α亚基水平异常升高,同时伴有垂体肿块病变。垂体腺瘤组织在经蝶窦手术时获取,免疫组织化学显示所有患者均有α亚基和TSHβ的表达。四例腺瘤免疫组织化学显示与生长激素或催乳素定位相关。在所有腺瘤的许多细胞核中均证实存在垂体特异性转录因子Pit-1。通过ISH检测,在所有五例患者的许多腺瘤细胞中均存在TSHβ mRNA信号。不仅在免疫定位显示两种激素产物均存在的四例腺瘤中检测到生长激素mRNA和催乳素mRNA的表达,而且在生长激素和催乳素免疫组织化学阴性的一例腺瘤中也检测到了它们的表达。ISH与免疫组织化学联合染色显示生长激素mRNA和催乳素mRNA在TSHβ免疫反应性细胞中表达。我们的研究结果表明,促甲状腺激素分泌型腺瘤可产生多种激素,可能起源于前体细胞或干细胞,而非分化的促甲状腺激素分泌细胞。提示ISH与免疫组织化学相结合可能为这种罕见类型腺瘤的多向组织发生提供更多详细信息。